Rapid Oral Fluid Screening Devices Market

Rapid Oral Fluid Screening Devices Market Outlook (2023 to 2033)

The global rapid oral fluid screening devices market accounts for a valuation of US$ 23.8 billion in 2023 and is forecasted to climb to US$ 47.3 billion by 2033-end. Fact.MR predicts global demand for rapid oral fluid screening devices to increase at a healthy 7.1% CAGR over the next ten years.

Rapid oral fluid screening devices allow a wide range of screening for the identification of drugs or other elements from oral samples. These devices are usually non-invasive in nature and this is a key aspect that is projected to uplift their demand throughout the forecast period and beyond.

Increasing alcohol consumption and surging use of illicit drugs are prime prospects that are anticipated to favor shipments of rapid oral fluid screening devices across the forecast period. Increasing investments in healthcare infrastructure development, the launch of new roadside testing initiatives, surging awareness regarding the benefits of rapid screening, growing use of rapid screening test kits by medical professionals, and expanding medical tourism activities are other factors that could benefit market development through 2033.

Surging prevalence of oral disorders and increasing preference for minimally invasive and non-invasive testing procedures are anticipated to open up new windows of opportunity for incoming as well as established rapid medical diagnostic kit suppliers over the coming years.

High spending of governments in improving road safety and implementation of mandatory drug and alcohol testing for suspected drivers by law enforcement authorities are also expected to boost rapid oral fluid screening device sales over the next ten years. On the flip side, the absence or lack of a favorable reimbursement scenario and high costs of research and development of novel rapid screening tests are anticipated to restrict overall rapid oral fluid screening device demand going forward.

Report Attributes	Details
Rapid Oral Fluid Screening Devices Market Size (2023)	US$ 23.8 Billion
Projected Market Value (2033F)	US$ 47.3 Billion
Global Market Growth Rate (2023 to 2033)	7.1% CAGR
Market Share of 6-Panel Saliva Drug Test Kits (2022)	>25%
Key Companies Profiled	OraSure Technologies Inc. MEDACX Ltd. Abbott Laboratories Oranoxis Inc. AccuBioTech Co. Ltd. Premier Biotech Inc. Guangzhou Wondfo Biotech Co. Ltd. UCP Biosciences Inc. SCREEN ITALIA SRL Securetec Detektions-Systeme AG

Which Pivotal Aspects Govern Rapid Oral Fluid Screening Device Sales?

“Ever-rising Incidence of Substance Abuse”

Drug abuse has become a major issue around the world in recent years and this is also a key factor that is slated to influence rapid oral fluid screening device shipments across the forecast period. Substance abuse and alcoholism are significantly more prevalent in the United States and Eastern European countries as compared to the rest of the world. Rising mortality rates due to drug abuse have pushed governments around the world to implement stringent mandates to regulate the distribution of drugs and even stricter laws to reduce substance abuse among people.

Rapid oral fluid screening devices allow faster detection of drug abuse to initiate efforts to help people battle their abuse and dependency issues. Surging demand for alcohol and drug testing around the world is also expected to uplift rapid oral fluid screening device sales over the next ten years.

Increasing popularity of telemedicine is also contributing to the increased trafficking of opioids and other drugs that could lead to substance abuse among individuals. All of the aforementioned factors are expected to result in the high use of rapid oral fluid screening devices to eradicate and manage substance and drug abuse issues in the global society.

“Increasing Number of People Driving Under Influence of Alcohol and Illicit Drugs”

Cases of driving under the influence of alcohol and illicit drugs were resulting in road accidents and to control the situation governments and law enforcement agencies around the world have been deploying rapid oral fluid screening devices for road screening. The short time for results provided by these rapid oral testing devices has proven their efficacy in combating drug-impaired driving issues.

Increasing investments by the government to promote the use of more advanced rapid oral fluid screening devices for roadside screening of drivers for drug impairment are also expected to bolster market growth in the future. Law enforcement agencies are testing new rapid screening devices that allow them to detect a variety of illicit drugs in a short period.

• In January 2023, the Police Department of Bakersfield, California, revealed that they were testing out a new rapid drug test to investigate drivers suspected to be driving under the influence. The new test was provided by Vanguard Laboratories, which is capable of detecting meth, cannabis, opioids, etc. in 3 to 5 minutes.

An exhaustive analysis of aspects such as product standards, safety regulations, pricing trends, and other factors affecting market development on a global and regional level have been listed in this latest rapid oral fluid screening devices market survey by analysts at Fact.MR, a market research and competitive intelligence provider.

Country-wise Insights

What’s Making the United Kingdom an Investment-worthy Market?

“Rising Consumption of Alcohol and Drugs in the Country”

Alcohol and drug consumption in European countries has been witnessing an upward trend in the past few years, which is expected to primarily drive rapid oral fluid screening device shipments in Europe over the coming years. The United Kingdom is anticipated to emerge as a highly remunerative space for rapid oral fluid screening device providers owing to rising cases of drug driving.

• As per an article published on volteface, on average a rise of 113% was recorded in drug-driving arrests from 2016 through 2021.

This surge in drug driving and drunk driving cases in the country is expected to bolster demand for novel roadside testing, which would subsequently favor sales of rapid oral fluid screening devices in the United Kingdom through 2033. Increasing investments in healthcare infrastructure development by public and private sectors and surging medical R&D activity are also projected to uplift the demand for rapid screening devices over the next ten years.

Why is the United States an Opportune Space for Rapid Oral Fluid Screening Device Suppliers?

“Rising Cases of Drunk Driving and Opioid Addiction”

Opioid addiction in the United States has become a major issue in the country over the past couple of decades and has also been dubbed as an epidemic citing major concerns regarding economic output and public health. Fentanyl, heroin, morphine, and codeine are some popular opioids that have influentially contributed to the opioid epidemic in the country.

• As per an article published by Council on Foreign Relations, the majority of overdose deaths recorded in the United States from the year 2000 were found to be linked to the use of opioids.

Increasing demand for drug testing in medical as well as professional establishments to curb controlled substance use and reduce mortality rates is projected to boost demand for rapid oral screening test kits in the United States throughout the forecast period and beyond. The rising number of fatalities due to drunk driving in the country is also expected to favor rapid oral fluid screening devices market development in the future.

• As per statistics provided by the National Highway Traffic Safety Administration (NHTSA) of the United States, more than 10,000 people die in drunk-driving accidents and reportedly accounted for nearly 1/3 of total traffic-related deaths in the country in 2019.

Category-wise Insights

Which Form of Rapid Oral Fluid Screening Device is Highly Sought-after?

“Strips Account for Commanding Market Share”

Based on form, the rapid oral fluid screening devices market is segmented into strips, swabs, and cassettes.

The highly portable nature and minimum inconvenience for the people being tested are prime advantages that drive demand for rapid oral fluid screening strip devices. The cost-effective nature of strips also makes them a preferred choice over cassettes and swabs, especially in emerging economies with tight spending budgets. The surging use of strips in the workplace and roadside testing applications is also anticipated to favor shipments of rapid oral fluid screening strips in the future.

Competitive Landscape

Leading rapid oral fluid screening device manufacturers are investing in research to develop and launch novel testing kits and solutions as global demand rises. Rapid oral fluid screening device start-ups are also stepping into the competitive landscape with their unique rapid oral fluid screening equipment which aids in solving key issues such as drug driving and substance abuse.

• Bloonics B.V., a start-up developing diagnostic solutions for the detection of cannabinoid activity, has developed a new technology that is claimed to measure THC impairment levels more accurately. The LuciX technology was expected to estimate when the person has taken cannabis and determine the probability of their impairment at the time of taking the test. This technology could revolutionize roadside drug testing for police and other authorities.

Rapid Oral Fluid Screening Devices Industry Research Segmentation

• By Drug Type :

  • Alcohol
  • Marijuana (THC)
  • Opioids
  • Cocaine
  • Amphetamines
  • Methamphetamines
  • Benzodiazepines
  • Others

• By Form :

  • Cassettes
  • Swabs
  • Strips

• By Product :

  • 1-Panel Saliva Drug Test Kits
  • 4-Panel Saliva Drug Test Kits
  • 5-Panel Saliva Drug Test Kits
  • 6-Panel Saliva Drug Test Kits
  • 7-Panel Saliva Drug Test Kits
  • 8-Panel Saliva Drug Test Kits
  • 9-Panel Saliva Drug Test Kits
  • 10-Panel Saliva Drug Test Kits
  • 12-Panel Saliva Drug Test Kits

• By End User :

  • Hospitals
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Private Employers
  • Home Care Settings

• By Region :

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA